Try our Advanced Search for more refined results

September 23, 2015

THE MEDICINES COMPANY v. BIOGEN MA INC.

Track this case

Case Number:

2:15-cv-07031

Court:

New Jersey

Nature of Suit:

Contract: Other

Judge:

Madeline Cox Arleo

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 07, 2018

    Biogen, Drugmaker Settle Angiomax Patent Royalties Row

    Biogen Inc. has settled a licensing dispute in a New Jersey federal court with a pharmaceutical company over whether the global biotech giant could keep collecting royalties on sales of the blood thinner Angiomax after the patent had expired.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login